These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12803925)

  • 21. Fabry disease: clinical spectrum and evidence-based enzyme replacement therapy.
    Desnick RJ; Banikazemi M
    Nephrol Ther; 2006 Jan; 2 Suppl 2():S172-85. PubMed ID: 17373219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipidomics in diagnosis of lipidoses.
    Wolf C; Quinn PJ
    Subcell Biochem; 2008; 49():567-88. PubMed ID: 18751927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Small-molecule therapeutics for the treatment of glycolipid lysosomal storage disorders.
    Butters TD; Mellor HR; Narita K; Dwek RA; Platt FM
    Philos Trans R Soc Lond B Biol Sci; 2003 May; 358(1433):927-45. PubMed ID: 12803927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycosphingolipid disorders of the brain.
    Boomkamp SD; Butters TD
    Subcell Biochem; 2008; 49():441-67. PubMed ID: 18751922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perspectives on gene therapy for lysosomal storage diseases that affect hematopoiesis.
    Grabowski GA
    Curr Hematol Rep; 2003 Jul; 2(4):356-62. PubMed ID: 12901334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Partial phenotypic correction and immune tolerance induction to enzyme replacement therapy after hematopoietic stem cell gene transfer of alpha-glucosidase in Pompe disease.
    Douillard-Guilloux G; Richard E; Batista L; Caillaud C
    J Gene Med; 2009 Apr; 11(4):279-87. PubMed ID: 19263466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved metabolic correction in patients with lysosomal storage disease treated with hematopoietic stem cell transplant compared with enzyme replacement therapy.
    Wynn RF; Wraith JE; Mercer J; O'Meara A; Tylee K; Thornley M; Church HJ; Bigger BW
    J Pediatr; 2009 Apr; 154(4):609-11. PubMed ID: 19324223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human trials: direct enzyme replacement--summary and discussion.
    Nadler HL
    Birth Defects Orig Artic Ser; 1980; 16(1):425-6. PubMed ID: 7004521
    [No Abstract]   [Full Text] [Related]  

  • 29. Neurological manifestations in lysosomal storage disorders - from pathology to first therapeutic possibilities.
    Hoffmann B; Mayatepek E
    Neuropediatrics; 2005 Oct; 36(5):285-9. PubMed ID: 16217702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current and emerging therapies for the lysosomal storage disorders.
    Pastores GM; Barnett NL
    Expert Opin Emerg Drugs; 2005 Nov; 10(4):891-902. PubMed ID: 16262569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma chitotriosidase in male Fabry patients: a marker for monitoring lipid-laden macrophages and their correction by enzyme replacement therapy.
    Vedder AC; Cox-Brinkman J; Hollak CE; Linthorst GE; Groener JE; Helmond MT; Scheij S; Aerts JM
    Mol Genet Metab; 2006 Nov; 89(3):239-44. PubMed ID: 16765076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnosis and treatment of Gaucher disease in Croatia].
    Mrsić M
    Lijec Vjesn; 2007 May; 129 Suppl 3():38-42. PubMed ID: 18959062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapy for the sphingolipidoses.
    Brady RO
    Arch Neurol; 1998 Aug; 55(8):1055-6. PubMed ID: 9708954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolution of enzyme replacement therapy for lipid storage diseases.
    Brady RO; Gal AE; Pentchev PG
    Life Sci; 1974 Oct; 15(7):1235-48. PubMed ID: 4220261
    [No Abstract]   [Full Text] [Related]  

  • 35. Letter: Enzyme-carrier potential of liposomes in enzyme replacement therapy.
    Gregoriadis G
    N Engl J Med; 1975 Jan; 292(4):215. PubMed ID: 1109221
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical experience in the treatment of gastrointestinal gas.
    Weiss J
    Med Times; 1969 Aug; 97(8):137-43. PubMed ID: 4894040
    [No Abstract]   [Full Text] [Related]  

  • 37. [Enzyme therapy of tumors].
    Bauer J
    Cas Lek Cesk; 1986 Nov; 125(48):1475-7. PubMed ID: 3802134
    [No Abstract]   [Full Text] [Related]  

  • 38. [Systemic enzyme therapy. Problems in absorption of enzyme macromolecules].
    Spácil J
    Cas Lek Cesk; 1996 May; 135(9):288. PubMed ID: 8706088
    [No Abstract]   [Full Text] [Related]  

  • 39. [Systemic enzyme therapy: problems of resorption of enzyme macromolecules].
    Nouza K; Wald M
    Cas Lek Cesk; 1995 Oct; 134(19):615-9. PubMed ID: 7585873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Preventive action of lactic enzymes on fungus diseases caused by antibiotic therapy].
    MASQUELIER J
    J Med Bord; 1959 Apr; 136(4):491-3. PubMed ID: 13654981
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.